Skip to Main Content
Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases
book

Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases

by Honghui Zhou, Diane R. Mould
March 2019
Intermediate to advanced content levelIntermediate to advanced
496 pages
15h
English
Wiley
Content preview from Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases

55Model‐Based Meta‐Analysis Use in the Development of Therapeutic Proteins

Timothy J. Taylor Bill Frame and Angela D. Taylor

Projections Research Inc., Pharmacometrics, 63 E. Shore Drive, Niantic, CT, 06357, USA

5.1 Introduction

Model‐based meta‐analysis (MBMA) is a method for combining summary or aggregate qualitative and quantitative study data from multiple studies to develop a single conclusion that has greater statistical power than one study alone, thus facilitating decisions during drug development. Individual studies sometimes fail to show statistically significant differences; multiple studies investigating the same clinical hypothesis often form a continuum of clinical experience and combining these study results leverages existing information. Since MBMA is based on aggregate (e.g. mean or median) results from large numbers of subjects from different studies and potentially different therapeutic agents, it increases the power to precisely detect significant effects across multiple studies, providing a basis for quantitative drug development decisions [1].

The term meta‐analysis was introduced by Glass in 1976 where in his paper on educational research he states, “Meta‐analysis refers to the analysis of analyses” [2]. The basic idea is to combine results from multiple scientific studies and analyze that data together as a whole. British mathematician Karl Pearson was the first to apply this method while reporting on inoculations to prevent enteric fever due to Salmonella ...

Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Start your free trial

You might also like

Applied Computing in Medicine and Health

Applied Computing in Medicine and Health

Dhiya Al-Jumeily, Abir Hussain, Conor Mallucci, Carol Oliver
Informatics for Health Professionals

Informatics for Health Professionals

Kathleen Mastrian, Dee McGonigle
Nanostructures for Novel Therapy

Nanostructures for Novel Therapy

Denisa Ficai, Alexandru Mihai Grumezescu

Publisher Resources

ISBN: 9781119289197Purchase book